Literature DB >> 1138541

Hepatic disease in erythropoietic protoporphyria.

J R Bloomer, M J Phillips, D L Davidson, G Klatskin.   

Abstract

Two sisters had erythropoietic protoporphyria and a spectrum of liver disease. One (F.B.) died in hepatic failure within 3 months after the development of jaundice. Only 10 months before she died, she had exhibited only bromsulfalein retention and a borderline increase in serum transaminase. Surgical exploration because of the jaundice revealed patency of the bile ducts which was confirmed at autopsy. Wedge biopsy and autopsy specimens of liver showed an active cirrhosis with massive amounts of protoporphyrin in Kupffer cells, portal histiocytes, bile canaliculi and parenchymal cytoplasm. The other sister (L.R.) had never had symptomatic liver disease and only a slight increase in serum transaminase and bromsulfalein retention. On needle biopsy, the liver specimen showed portal inflammation with erosion of limiting plates, occasional bridging between triads and central areas of cell dropout. Protoporphyrin pigment was present in portal histiocytes, areas of central collapse and, more rarely, in parenchymal cytoplasm. These studies demonstrate that significant, progressive hepatic disease may occur insidiously in erythropoietic protoporphyria, and that once jaundice appears it may be followed rapidly by fatal hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138541     DOI: 10.1016/0002-9343(75)90644-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Toxic dark effects of protoporphyrin on the cytochrome P-450 system in rat liver microsomes.

Authors:  M Williams; J Van der Zee; J Van Steveninck
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.

Authors:  John Phillips; Collin Farrell; Yongming Wang; Ashwani K Singal; Karl Anderson; Manisha Balwani; Montgomery Bissell; Herbert Bonkovsky; Toni Seay; Barry Paw; Robert Desnick; Joseph Bloomer
Journal:  Mol Genet Metab       Date:  2018-10-22       Impact factor: 4.797

3.  Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.

Authors:  Manisha Balwani; Hetanshi Naik; Karl E Anderson; D Montgomery Bissell; Joseph Bloomer; Herbert L Bonkovsky; John D Phillips; Jessica R Overbey; Bruce Wang; Ashwani K Singal; Lawrence U Liu; Robert J Desnick
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

4.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 5.  Erythropoietic protoporphyria.

Authors:  T M Cox
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

7.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

8.  Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.

Authors:  Yongming Wang; Nathaniel B Langer; George C Shaw; Guang Yang; Liangtao Li; Jerry Kaplan; Barry H Paw; Joseph R Bloomer
Journal:  Exp Hematol       Date:  2011-05-11       Impact factor: 3.084

9.  Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.

Authors:  M B Poh-Fitzpatrick; J A Sklar; C Goldsman; J H Lefkowitch
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  A molecular defect in human protoporphyria.

Authors:  D A Brenner; J M Didier; F Frasier; S R Christensen; G A Evans; H A Dailey
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.